Paola Perfetti
YOU?
Author Swipe
View article: Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy Open
Chimeric antigen receptor (CAR)-T cell therapy is a powerful adoptive immunotherapy associated with significant toxicity, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). As CAR-…
View article: The European Trauma Course: Transforming systems through training
The European Trauma Course: Transforming systems through training Open
View article: Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making Open
Summary In a first‐of‐its‐kind study, we assessed the capabilities of large language models (LLMs) in making complex decisions in haematopoietic stem cell transplantation. The evaluation was conducted not only for Generative Pre‐trained Tr…
View article: PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES Open
Topic: 4. Acute myeloid leukemia - Clinical Background: Acute myeloid leukemia “myelodysplasia-related” and “post-cytotoxic therapies”, as defined by 2022 WHO classification, previously named AML-MRC and therapy-related AML, represent very…